2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten

C87H101N24O4W- — CID 158604017

IUPAC2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten
SMILESC.C.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nnc(C)n4C(C)C)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.[CH3-].[W]
InChIInChI=1S/C33H36N8O2.C26H26N8O.C25H28N8O.2CH4.CH3.W/c1-20(2)41-22(4)38-39-32(41)27-7-6-8-31(36-27)37-33(42)26-16-30(40-18-29(35-19-40)24-11-12-24)21(3)15-28(26)34-17-23-9-13-25(43-5)14-10-23;1-15(2)34-17(4)30-31-25(34)20-6-5-7-24(29-20)33-14-28-21-10-16(3)23(11-19(21)26(33)35)32-12-22(27-13-32)18-8-9-18;1-14(2)33-16(4)30-31-24(33)20-6-5-7-23(28-20)29-25(34)18-11-22(15(3)10-19(18)26)32-12-21(27-13-32)17-8-9-17;;;;/h6-10,13-16,18-20,24,34H,11-12,17H2,1-5H3,(H,36,37,42);5-7,10-15,18H,8-9H2,1-4H3;5-7,10-14,17H,8-9,26H2,1-4H3,(H,28,29,34);2*1H4;1H3;/q;;;;;-1;
InChIKeyNYHOLINORIXLRF-UHFFFAOYSA-N
MW1730.77 g/mol
LogP16.93
Rot. Bonds21

About 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten

2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten (PubChem CID 158604017) has the molecular formula C87H101N24O4W- and a molecular weight of 1730.77 g/mol. Its IUPAC name is 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten.

Molecular Properties

Compound Name2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten
PubChem CID158604017
Molecular FormulaC87H101N24O4W-
Molecular Weight1730.77 g/mol
Exact Mass1729.80
IUPAC Name2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten
SMILESC.C.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nnc(C)n4C(C)C)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.[CH3-].[W]
InChIInChI=1S/C33H36N8O2.C26H26N8O.C25H28N8O.2CH4.CH3.W/c1-20(2)41-22(4)38-39-32(41)27-7-6-8-31(36-27)37-33(42)26-16-30(40-18-29(35-19-40)24-11-12-24)21(3)15-28(26)34-17-23-9-13-25(43-5)14-10-23;1-15(2)34-17(4)30-31-25(34)20-6-5-7-24(29-20)33-14-28-21-10-16(3)23(11-19(21)26(33)35)32-12-22(27-13-32)18-8-9-18;1-14(2)33-16(4)30-31-24(33)20-6-5-7-23(28-20)29-25(34)18-11-22(15(3)10-19(18)26)32-12-21(27-13-32)17-8-9-17;;;;/h6-10,13-16,18-20,24,34H,11-12,17H2,1-5H3,(H,36,37,42);5-7,10-15,18H,8-9H2,1-4H3;5-7,10-14,17H,8-9,26H2,1-4H3,(H,28,29,34);2*1H4;1H3;/q;;;;;-1;
InChIKeyNYHOLINORIXLRF-UHFFFAOYSA-N
XLogP16.93
TPSA324.63 Ų
H-Bond Donors4
H-Bond Acceptors26
Rotatable Bonds21
Heavy Atoms116
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001730.77
LogP ≤ 516.93
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten?
The IUPAC name of 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten (CID 158604017) is 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten.
What is the SMILES notation for 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten?
The canonical SMILES for 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten is C.C.COc1ccc(CNc2cc(C)c(-n3cnc(C4CC4)c3)cc2C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1.Cc1cc(N)c(C(=O)Nc2cccc(-c3nnc(C)n3C(C)C)n2)cc1-n1cnc(C2CC2)c1.Cc1cc2ncn(-c3cccc(-c4nnc(C)n4C(C)C)n3)c(=O)c2cc1-n1cnc(C2CC2)c1.[CH3-].[W].
What is the InChIKey of 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten?
The InChIKey is NYHOLINORIXLRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H36N8O2.C26H26N8O.C25H28N8O.2CH4.CH3.W/c1-20(2)41-22(4)38-39-32(41)27-7-6-8-31(36-27)37-33(42)26-16-30(40-18-29(35-19-40)24-11-12-24)21(3)15-28(26)34-17-23-9-13-25(43-5)14-10-23;1-15(2)34-17(4)30-31-25(34)20-6-5-7-24(29-20)33-14-28-21-10-16(3)23(11-19(21)26(33)35)32-12-22(27-13-32)18-8-9-18;1-14(2)33-16(4)30-31-24(33)20-6-5-7-23(28-20)29-25(34)18-11-22(15(3)10-19(18)26)32-12-21(27-13-32)17-8-9-17;;;;/h6-10,13-16,18-20,24,34H,11-12,17H2,1-5H3,(H,36,37,42);5-7,10-15,18H,8-9H2,1-4H3;5-7,10-14,17H,8-9,26H2,1-4H3,(H,28,29,34);2*1H4;1H3;/q;;;;;-1;.
What are the key properties of 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten?
2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten has a molecular weight of 1730.77 g/mol, XLogP of 16.93, 21 rotatable bonds, 4 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-(4-cyclopropylimidazol-1-yl)-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;carbanide;5-(4-cyclopropylimidazol-1-yl)-2-[(4-methoxyphenyl)methylamino]-4-methyl-N-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide;6-(4-cyclopropylimidazol-1-yl)-7-methyl-3-[6-(5-methyl-4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]quinazolin-4-one;methane;tungsten is sourced from PubChem (CID 158604017), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).